SCHD hits a new 52-week high as investors seek high income amid market uncertainty.
The Schwab U.S. Dividend Equity ETF has outperformed the S&P 500 year-to-date, silencing the detractors who thought it could never outshine. SCHD offers less aggressive and volatile portfolio positioning with sector allocations favoring Healthcare (20.7%), Consumer Defensive (19%), and Energy (14%), plus +3.2% dividend yield. Top SCHD holdings — Home Depot, Merck, UnitedHealth, Amgen — are A+ rated for profitability, supporting the ETF's focus on dividend quality and stability.
SCHD's focus on defensive, high-quality dividend stocks and sector diversification has delivered robust total return prospects across dividend yield, payout growth, and capital appreciation. Their exposure to inelastic healthcare/household/communication sectors underpin their resilience amid macro/geopolitical uncertainty and higher-for-longer inflation expectations. This is on top of the focus on discounted stocks offering robust dividend yields/payout growth, with further upside possible upon upward valuation re-rating.
I have a soft spot for the Schwab U.S. Dividend Equity ETF (SCHD).
The Schwab U.S. Dividend Equity ETF (SCHD) continues to be one of my favorite dividend ETFs.
The Schwab US Dividend Equity ETF ( NYSEARCA :SCHD ) made an exceptionally strong comeback earlier this year and has returned more than even the Invesco QQQ Trust ( NASDAQ :QQQ ) , if you count dividends.
Retirement income planning used to mean picking the highest yield you could find and hoping it held up.
You're approaching retirement and have $300,000 parked in a savings account or a checking account earning close to nothing, while your bank's own website advertises a 1.65% average on a 12-month CD.
You bought Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) because the sticker price looked unbeatable: 6 basis points, a rounding error.
Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) pays a quarterly distribution from roughly 100 quality-screened U.S.
SCHD is now rated buy, while DLN is downgraded to Hold. SCHD's concentrated, defensive, and relatively rate-agnostic value positioning outperformed both DLN and the S&P 500 in a slower, rotation-driven market. DLN's supposed growth tilt is overstated; its tech exposure does not materially capture AI-led rallies and is more defensive in nature.
Schwab US Dividend Equity ETF remains a 'sell' due to persistent underperformance versus market indices and curated high-yield portfolios. SCHD's 3.29% yield and low 0.06% expense ratio are outweighed by its lagging total returns over most timeframes. While SCHD offers diversification and can outperform during volatility, it fails to deliver superior long-term yield or upside.